Latest News and Publications about Professor Gazzard
The Moorfields Glaucoma Service Director Professor Gus Gazzard discusses a non-invasive glaucoma treatment that could reduce the need for eye drops. Includes a 7 minute video interview with Professor Gazzard by Optometry Today.
NIHR: Professor Gus Gazzard publishes ground-breaking research
The National Institute for Health Research (NIHR) Dissemination Centre has published an NIHR Signal on Professor Gazzard’s research.
You can read the Signal here: A laser eye procedure can be effective and safe if used early as a treatment for glaucoma.
Video interview for World Glaucoma Week
Professor Gazzard reflects on his pioneering glaucoma research in the following video shot at World Glaucoma Week
The Lancet: Laser trabeculoplasty as first-line glaucoma treatment
The prestigious medical journal The Lancet published results from a pioneering research study, funded by the National Institute of Health Research (NIHR) and led by Professor Gus Gazzard.
The Daily Mail: Patient Experience with Glaucoma Diagnosis
An article from the Daily Mail where Professor Gazzard is quoted about Glaucoma: please read the article here: https://www.dailymail.co.uk/health/article-7747863/Woman-59-recalls-migraine-warning-sign-starting-blind.html
The Daily Mail: “Me and My Operation: Laser for glaucoma, a painless blast of light to stop you going blind”
“A laser could end the inconvenience of eye drops for glaucoma” – Article in the Daily Mail 26.08.19
Guy Staniforth, 62, a project engineer from Greenwich in South-East London, tells ADRIAN MONTI about having the operation by Professor Gazzard.
Positive effects of Hydrus plus phaco persist
PARIS — The HORIZON trial at 3 years demonstrated that the Hydrus Schlemm’s canal stent added sustained IOP lowering to that achieved by cataract surgery alone, Gus Gazzard, MD, MBBChir, FRCOphth, said at the European Society of Cataract and Refractive Surgeons meeting.
“That intraocular pressure was stable, significantly better than control after 3 years,” Gazzard said.
The Ophthalmologist: “Time to Transform Glaucoma Treatment Paradigm”
SLT is an effective intervention for newly-diagnosed patients – and now we can prove it. Article about the research conducted by Professor Gazzard.
UCL Institute of Ophthalmology: Gus Gazzard appointed Professor of Glaucoma Studies
Speaking of his promotion and clinical trials, Gus said: “I am honoured to have been appointed to a UCL Professorship and I look forward to further developing the clinical trials and excellent postgraduate clinical education that we have established here at the UCL Institute of Ophthalmology. The clinical trials that I work on across the globe are a testament to the great team that I’ve been able to build at the Institute of Ophthalmology and Moorfields Eye Hospital, and a tribute to all of their hard work – the energy they bring to answer questions of real clinical importance to patients with blinding diseases.”
The Guardian: “15 Minute Laser Treatment Best For Glaucoma Patients”
Lasers should become the principal method in the UK for treating patients with the debilitating eye condition glaucoma. That is the stark conclusion of a three-year study published recently.
FLIPBOOK by Moorfields Eye Charity Magazine Feature
The Moorfields Eye Charity Flipbook magazine has a feature articles on Professor Gazzard’s innovative research.
Professor Gazzard now performs the innovative Hydrus Stent Procedure
Professor Gazzard is now one of only three surgeons performing the innovative Hydrus stent procedure in the UK.
You can read more about the Hydrus procedure here or you can download a PDF about Hydrus here.
Professor Gazzard authors ‘Definitive Review of Data’
Professor Gus Gazzard is the author of this definitive review of the data on the main treatment for angle closure glaucoma.
NHS NATIONAL BRONZE MERIT AWARD WINNER
Gus has been awarded the prestigious, competitively awarded “NHS National Bronze Merit Award”.
These awards recognise NHS consultants who perform ‘over and above’ the standard expected of their role.
NICE Report on Trabecular Stent Bypass Microsurgery
NICE (National Institute for Health and Care Excellence) have released a report on Trabecular stent bypass microsurgery for open-angle glaucoma
Links to Other Articles about Professor Gazzard
- European School for Advanced Studies in Ophthalmology
- Optometry Today | Taking stock of glaucoma implants
- Royal Academy of Ophthamologists ‘focus’ article: Minimally Invasive Glaucoma Surgery (MIGS)
- IRIS
- EGS ACG SIG meeting (PDF)
- PubMed
- Interview with one of Professor Gazzard’s patients in the Mail Online
- UK Clinical Research Network paper on the LiGHT SLT Trial Research
- GoodDoctor review
- Moorfields Eye Charity feature